Urine test could save industry money
A simple urine sample could soon be used to predict the complex toxic effects of new drugs potentially making clinical trials safer, more effective, and saving the industry millions of euros.
Archives for March 26, 2004
Evotec takes on tricky CNS target
Germany's Evotec Neurosciences, a subsidiary of Evotec OAI, has licensed rights to a patent portfolio developed by Roche that covers a promising - but elusive - drug target for central nervous system (CNS) disorders, reports Phil Taylor.